Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting - Exagen (NASDAQ:XGN)
SAN DIEGO, California, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, announced today the acceptance of five abstracts at the 2023 American College of
United States San Diego Convention Center San Diego County San Diego Ryan Douglas United States Community Rheumatologist Practice
Source: benzinga.com